Lebrikizumab, A High-Affinity Il-13 Inhibitor, Improves Atopic Dermatitis Similarly Well Across Different Anatomic Regions
ACTA DERMATO-VENEREOLOGICA（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined